Overcoming the diagnostic gap in mild cognitive impairment in Parkinson’s disease: a pilot study employing a machine learning-/augmented reality-based digital biomarker

BackgroundCognitive impairment is a clinically significant, non-motor symptom of Parkinson’s disease (PD) commonly associated with reduced quality of life, increased caregiver burden, and higher risk of progression to dementia. Mild cognitive impairment in PD (PD-MCI) is expressed heterogeneously, w...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Karolina Poplawska-Domaszewicz, Emmanuel Streel, Aleksandra Brek, Natalia Miśko, Ewa Kosińska, Vinod Metta, Per Odin, Angelo Antonini, Roberta Biundo, Eleonora Fiorenzato, Kit Wu, Saivansh Chopra, Srikaanth Haridas, Ioannis Tarnanas, Nicholas Griffin, Victoria Brugada-Ramentol, M Florencia Iulita, Madison Jones, Slawomir Michalak, Wojciech Kozubski, Kallol Ray Chaudhuri
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2026-06-01
Colecção:	Frontiers in Aging Neuroscience
Assuntos:	cholinergic cognition digital biomarkers mild cognitive impairment Parkinson’s disease
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fnagi.2026.1839000/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!